The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile-Reference-Cited by-同舟云学术

The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile

Published:2008-11-21 Issue:16 Volume:23 Page:2398-2403
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Goetz Christopher G.,Nutt John G.,Stebbins Glenn T.

Funder

Michael J. Fox Foundation

EMD/Merck KGaA Pharmaceuticals

Parkinson's Disease Foundation Research Center

National Parkinson Disease Center of Excellence

NIH

Biogen Boehringer-Ingelheim

Ceregene

EMD Pharmaceuticals

Impax

I3 Research

Juvantia

Kiowa

GlaxoSmith Kline

Merck KGaA

Merck and Co.

Neurim

Novartis

Ovation

Oxford Biomedica

Schering-Plough

Solstice Neuroscience

Solvay

Synergy/Intec

Teva Pharmaceuticals

Fragile X Foundation

Kinetics Foundation

Kinetics Fdn

National Parkinson Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.22341/fullpdf

Reference24 articles.

1. Levodopa-induced dyskinesias;Fabbrini;Mov Disord,2007

2. Motor fluctuations and dyskinesias in Parkinson's disease;Nutt;Parkkinsonism Relat Disord,2001

3. Drug insight: new drugs in development for Parkinson's disease;Colosimo;Nat Clin Pract Neurol,2006

4. Pathophysiology of levodopa-induced dyskinesia: potential or new therapies;Bézard;Nat Rev Neurosci,2001

5. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease;Rascol;Mov Disord,2001

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Learning Spatio-Temporal Radon Footprints for Assessment of Parkinson’s Dyskinesia;Electronics;2024-02-02

2. A Double‐Blind, Randomized, Placebo‐Controlled Trial of Bumetanide in Parkinson's Disease;Movement Disorders;2024-01-30

3. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation;Journal of Patient-Reported Outcomes;2024-01-04

4. Microstructural and functional alterations of the ventral pallidum are associated with levodopa‐induced dyskinesia in Parkinson's disease;European Journal of Neurology;2023-11-17

5. Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration;Neuropharmacology;2023-10